Cygnal Therapeutics Email Format

Biotechnology ResearchMassachusetts, United States11-50 Employees

Cygnal Therapeutics is a Cambridge, Massachusetts-based biotechnology company focused on exoneural biology, a field it views as broadly linked to health and disease. It has developed the Exoneural Medicine Platform to enable drug discovery and development in this area, with an initial focus on cancer and inflammatory diseases. By applying this platform, the company aims to create new medicines across multiple therapeutic areas that engage exoneural biology.

The company was founded in 2017 by Flagship Pioneering. As a relatively small organization within the biotechnology research sector, it targets the development of therapies for patients affected by cancer and inflammatory conditions. A notable leadership development occurred in 2020 when John A. Wagner joined the company as chief medical officer.

Sign up for free to view info

Company overview Employee directory